BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 36307664)

  • 1. Comparison of surgery with or without adjuvant radiotherapy in treating central neurocytoma: a single-center retrospective real-world study.
    She L; Deng D; Su L; Liu C
    J Neurooncol; 2022 Nov; 160(2):455-462. PubMed ID: 36307664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term outcomes of adjuvant radiotherapy after surgical resection of central neurocytoma.
    Chen YD; Li WB; Feng J; Qiu XG
    Radiat Oncol; 2014 Nov; 9():242. PubMed ID: 25373333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Outcomes and Prognostic Analysis of 101 Patients of Central Neurocytoma: A 10-Year Treatment Experience at a Single Institution.
    Xie Q; Xie B; Ou L; Wang M; Tang Z; He Y; Yang X; Hong J; Lyu Z; Wei R
    Front Oncol; 2022; 12():881460. PubMed ID: 35692765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Features, Treatment, and Long-term Outcomes of Central Neurocytoma: A 20-Year Experience at a Single Center.
    Wang M; Zhou P; Zhang S; Liu X; Lv L; Wang Z; Ye F; Wang X; Jiang S
    World Neurosurg; 2018 Jan; 109():e59-e66. PubMed ID: 28958923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
    Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
    J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary Skull Base Chordomas: A Clinicopathological Analysis of 94 Patients.
    Zhao L; Chang C; Zhuang Y; Wang B; Qin L; Zheng JJ; You YP; Liu N; Ji J; Zheng K
    World Neurosurg; 2023 Jul; 175():e841-e854. PubMed ID: 37068608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical prognostic factors for central neurocytoma and subgroup analysis of different treatment measures: A SEER database-based retrospective analysis from 2003 to 2019.
    Zhang Z; Yu J; Zhang C; Pang X; Wei Y; Lv Q; Chen H; Jin X; Zhan R
    Front Oncol; 2022; 12():1014506. PubMed ID: 36686752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical Central Neurocytoma: An Investigation of Prognostic Factors.
    AbdelBari Mattar M; Shebl AM; Toson EA
    World Neurosurg; 2021 Feb; 146():e184-e193. PubMed ID: 33091649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcome and prognostic factors for central neurocytoma: twenty year institutional experience.
    Imber BS; Braunstein SE; Wu FY; Nabavizadeh N; Boehling N; Weinberg VK; Tihan T; Barnes M; Mueller S; Butowski NA; Clarke JL; Chang SM; McDermott MM; Prados MD; Berger MS; Haas-Kogan DA
    J Neurooncol; 2016 Jan; 126(1):193-200. PubMed ID: 26493740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiotherapy after surgery for benign cerebral meningioma.
    Soyuer S; Chang EL; Selek U; Shi W; Maor MH; DeMonte F
    Radiother Oncol; 2004 Apr; 71(1):85-90. PubMed ID: 15066300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of resection and adjuvant therapy in long-term disease outcomes for low-grade pediatric intramedullary spinal cord tumors.
    Ahmed R; Menezes AH; Torner JC
    J Neurosurg Pediatr; 2016 Nov; 18(5):594-601. PubMed ID: 27420482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
    Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
    J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individual Treatment Decisions for Central Neurocytoma.
    Han S; Yang Z; Yang Y; Qi X; Yan C; Yu C
    Front Neurol; 2020; 11():834. PubMed ID: 32922351
    [No Abstract]   [Full Text] [Related]  

  • 14. The superiority of conservative resection and adjuvant radiation for craniopharyngiomas.
    Schoenfeld A; Pekmezci M; Barnes MJ; Tihan T; Gupta N; Lamborn KR; Banerjee A; Mueller S; Chang S; Berger MS; Haas-Kogan D
    J Neurooncol; 2012 May; 108(1):133-9. PubMed ID: 22350375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas.
    Kaur G; Kane AJ; Sughrue ME; Oh M; Safaee M; Sun M; Tihan T; McDermott MW; Berger MS; Parsa AT
    J Clin Neurosci; 2013 Jan; 20(1):89-93. PubMed ID: 23137668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of proton beam therapy in central neurocytoma: A single-institution experience.
    Kang KH; Schapira E; Niemierko A; Martinez-Lage M; Bussière MR; Yock TI; Loeffler JS; Butler WE; Carter BS; Shih HA
    Pract Radiat Oncol; 2018; 8(5):e305-e311. PubMed ID: 29706302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas.
    Oh MC; Ivan ME; Sun MZ; Kaur G; Safaee M; Kim JM; Sayegh ET; Aranda D; Parsa AT
    Neuro Oncol; 2013 Feb; 15(2):208-15. PubMed ID: 23229996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skull base atypical meningioma: long term surgical outcome and prognostic factors.
    Wang YC; Chuang CC; Wei KC; Hsu YH; Hsu PW; Lee ST; Wu CT; Tseng CK; Wang CC; Chen YL; Jung SM; Chen PY
    Clin Neurol Neurosurg; 2015 Jan; 128():112-6. PubMed ID: 25486076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of adjuvant radiotherapy in the intracranial hemangiopericytoma.
    Jeon SH; Park SH; Kim JW; Park CK; Paek SH; Kim IH
    J Neurooncol; 2018 May; 137(3):567-573. PubMed ID: 29327171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative Adjuvant Radiotherapy in Atypical Meningioma Patients: A Meta-Analysis Study.
    Song D; Xu D; Han H; Gao Q; Zhang M; Wang F; Wang G; Guo F
    Front Oncol; 2021; 11():787962. PubMed ID: 34926303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.